Injection Site Mass
18 drugs7,706 FAERS reportsMedDRA PT
GET
/api/v1/reaction/injection-site-massReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Injection Site Mass (18)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Niobium1100%
- 2Tantalum1100%
- 3Vitamin B6120%
- 4Clesrovimab19.1%
- 5Lenacapavir348.2%
- 6Sibeprenlimab35.3%
- 7Naltrexone1,9154.8%
- 8Lanreotide3654.8%
- 9Rilonacept363.7%
- 10Glatiramer2,2673.7%
- 11Aripiprazole Lauroxil1443.2%
- 12Asfotase Alfa2843.0%
- 13Tesamorelin432.9%
- 14Interferon Beta-1b4822.5%
- 15Degarelix1272.5%
- 16Somatrogon262.2%
- 17Leuprolide1,3671.8%
- 18Ixekizumab6091.7%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Injection Site Swelling9 shared · 0.28
- Injection Site Pruritus9 shared · 0.26
- Injection Site Reaction7 shared · 0.21
- Injection Site Erythema9 shared · 0.18
- Injection Site Bruising7 shared · 0.18
- Injection Site Discomfort3 shared · 0.15
- Injection Site Pain18 shared · 0.13
- Injection Site Haemorrhage3 shared · 0.11
- Injection Site Thrombosis2 shared · 0.11
- Lipoma2 shared · 0.11
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.